RELMADA THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Relmada Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q2 2015 to Q3 2024.
  • Relmada Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $22K, a 53.9% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $22K -$25.7K -53.9% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $53.6K +$19K +55% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $43.1K +$8.25K +23.7% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $43.1K +$8.25K +23.7% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $47.7K +$31.6K +196% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $34.6K -$648 -1.84% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $34.9K +$6.58K +23.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $34.9K +$6.58K +23.3% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $16.1K -$8.91K -35.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $35.2K +$10.2K +41% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $28.3K +$3.29K +13.2% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $28.3K +$3.29K +13.2% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $25K $0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $25K $0 0% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $25K $0 0% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $25K $0 0% Dec 31, 2020 10-K 2022-03-25
Q3 2020 $25K $0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $25K $0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $25K -$18.9K -43.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $25K +$6.09K +32.2% Dec 31, 2019 10-K 2021-03-24
Q3 2019 $25K +$6.09K +32.2% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $25K +$212 +0.86% Jun 30, 2019 10-K 2021-03-24
Q1 2019 $43.9K +$22.3K +103% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $18.9K -$3.05K -13.9% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 $18.9K -$3.05K -13.9% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $24.8K +$2.83K +12.9% Jun 30, 2018 10-KT 2020-03-26
Q1 2018 $21.6K -$393K -94.8% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $22K -$393K -94.7% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 $22K -$393K -94.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $22K -$392K -94.7% Jun 30, 2017 10-K 2018-09-28
Q1 2017 $415K +$2.22K +0.54% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $415K Dec 31, 2016 10-Q 2017-02-10
Q3 2016 $415K Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $414K +$13.5K +3.38% Jun 30, 2016 10-K 2017-09-28
Q1 2016 $413K Mar 31, 2016 10-Q 2016-05-09
Q2 2015 $401K Jun 30, 2015 10-K 2016-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.